Related Experiment Video
Updated: Jun 13, 2026
02:28
Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Psoriatic arthritis--what the dermatologist needs to know
1Dermatological Sciences, Salford Royal NHS Foundation Trust arc-EU, Stopford Building, The University of Manchester, Manchester, M13 9PT, UK.
Summary
Psoriasis patients may develop psoriatic arthritis (PsA), a related joint condition. Early diagnosis and treatment by dermatologists can prevent joint damage, highlighting the need for awareness of PsA diagnosis and management.
Area of Science:
- Dermatology and Rheumatology
- Immunology and Inflammation
Background:
- Psoriasis frequently co-exists with psoriatic arthritis (PsA).
- Dermatologists may overlook early psoriatic arthritis, delaying crucial joint-protective interventions.
- PsA is a sero-negative arthritis, meaning rheumatoid factor is typically absent.
Purpose of the Study:
- To review diagnostic criteria for early-stage psoriatic arthritis.
- To outline clinical indicators for rheumatologist referral in psoriatic patients.
- To discuss current and evolving treatment strategies for psoriasis and PsA.
Main Methods:
- Literature review of diagnostic criteria for psoriatic arthritis.
- Analysis of clinical signs prompting rheumatology consultation.
- Synthesis of evidence on therapeutic options for psoriasis and PsA.
Main Results:
- Established diagnostic criteria for psoriatic arthritis are presented.
- Key clinical indications for rheumatologist referral are identified.
- An overview of treatment advancements for both psoriasis and PsA is provided.
Conclusions:
- Timely recognition of PsA by dermatologists is vital for preventing irreversible joint damage.
- Understanding referral criteria ensures appropriate patient management.
- Integrated treatment approaches benefit patients with co-existing psoriasis and PsA.
